FGFR3 and neoplasm: Mutations of FGFR3 are strongly associated with a low tumour grade and stage, with up to 60–70% of low-grade pTa tumours showing these mutations (Billerey et al, 2001; van Rhijn et al, 2001; Jebar et al, 2005).